Medical Properties Trust (NYSE:MPT) Rating Lowered to Neutral at BNP Paribas Exane

Key Points

• BNP Paribas Exane downgraded Medical Properties Trust from “outperform” to “neutral” and set a $2.25 price target, implying roughly 3.2% upside from the reported share price.
• Analyst sentiment remains strongly negative: MPT has an average “strong sell” rating and a consensus price target of $2.68, following recent downgrades from Wells Fargo, Weiss Ratings, and RBC.
• MPT shares opened at $2.18 after falling 3.1%; the company’s latest quarterly earnings of $0.11 per share missed estimates, although revenue rose 5.3% year over year to $250.14 million.

Medical Properties Trust (NYSE:MPT - Get Free Report) was downgraded by equities researchers at BNP Paribas Exane from an "outperform" rating to a "neutral" rating in a research note issued on Tuesday, Briefing.com reports. They presently have a $2.25 price target on the stock. BNP Paribas Exane's target price would indicate a potential upside of 3.21% from the company's current price.

MPT has been the topic of a number of other research reports. Wells Fargo & Company reduced their price objective on Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research report on Tuesday, September 1st. Weiss Ratings lowered Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 18th. Finally, Royal Bank Of Canada cut Medical Properties Trust from a "sector perform" rating to an "underperform" rating and reduced their price target for the stock from $4.50 to $2.00 in a report on Friday. One investment analyst has rated the stock with a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Medical Properties Trust presently has an average rating of "Strong Sell" and a consensus price target of $2.68.

Medical Properties Trust Trading Down 3.1%

Shares of MPT stock opened at $2.18 on Tuesday. The stock has a 50 day simple moving average of $3.38 and a 200 day simple moving average of $4.34. The stock has a market cap of $1.30 billion, a P/E ratio of 5.32 and a beta of 1.45. The company has a current ratio of 3.12, a quick ratio of 3.12 and a debt-to-equity ratio of 2.16. Medical Properties Trust has a 1 year low of $2.03 and a 1 year high of $6.47.

Medical Properties Trust (NYSE:MPT - Get Free Report) last released its earnings results on Thursday, October 29th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.02). Medical Properties Trust had a negative return on equity of 0.66% and a negative net margin of 2.96%. The business had revenue of $250.14 million for the quarter. Medical Properties Trust's revenue was up 5.3% compared to the same quarter last year. On average, research analysts predict that Medical Properties Trust will post 0.53 earnings per share for the current fiscal year.

Institutional Trading of Medical Properties Trust

A number of institutional investors have recently bought and sold shares of MPT. CoreCap Advisors LLC acquired a new position in shares of Medical Properties Trust during the 3rd quarter valued at $27,000. Continuum Advisory LLC acquired a new stake in Medical Properties Trust in the second quarter worth $31,000. NFSG Corp bought a new stake in Medical Properties Trust in the third quarter valued at $34,000. Frank Rimerman Advisors LLC bought a new stake in Medical Properties Trust in the third quarter valued at $35,000. Finally, Choreo LLC bought a new stake in Medical Properties Trust in the third quarter valued at $35,000. Institutional investors own 71.79% of the company's stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a healthcare-focused real estate investment trust (REIT) that owns and invests in healthcare facilities. Its portfolio has historically included hospitals, inpatient rehabilitation facilities, long-term acute-care hospitals, behavioral health facilities and other properties used by healthcare providers.

Founded in 2003 and headquartered in Birmingham, Alabama, the company primarily generates income by leasing properties to healthcare operators under long-term agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.